Published ahead of print on September 21, 2006, doi:10.1165/rcmb.2006-0133OC
American Journal of Respiratory Cell and Molecular Biology. Vol. 36, pp. 270-275, 2007
© 2007 American Thoracic Society DOI: 10.1165/rcmb.2006-0133OC
Epithelial Cell Apoptosis by Fas LigandPositive Myofibroblasts in Lung Fibrosis
Regina Golan-Gerstl,
Shulamit B. Wallach-Dayan,
Gail Amir and
Raphael Breuer
Lung Cellular and Molecular Biology Laboratory, Institute of Pulmonary Medicine, and Department of Pathology, HadassahHebrew University Medical Center, Jerusalem, Israel; and Department of Pathology, Boston University School of Medicine, Boston, Massachusetts
Correspondence and requests for reprints should be addressed to Raphael Breuer, M.D., Institute of Pulmonary Medicine, HadassahHebrew University Medical Center, P.O.B. 12,000, Jerusalem, Israel 91120. E-mail: raffi{at}hadassah.org.il
The Fas/Fas ligand (FasL) apoptotic pathway has been shown to be involved in bleomycin-induced lung fibrosis. We examined the hypothesis that myofibroblasts from fibrotic lungs possess a cytotoxic phenotype that causes apoptosis of epithelial cells via the Fas/FasL pathway. We show in vivo epithelial cell apoptosis and associated upregulation of Fas and apoptotic Fas pathway genes in epithelial cells of lungs with bleomycin-induced fibrosis. In addition, we show that FasL surface molecules are overexpressed on -SMApositive cells in mice with bleomycin-induced fibrosis, and in humans with idiopathic pulmonary fibrosis. This enables the molecules to kill Fas-positive epithelial cells. In contrast, FasL-deficient myofibroblasts lose this myofibroblast cytotoxic phenotype, both in vivo and in vitro. In vivo, there was no bleomycin-induced epithelial cell apoptosis, as assessed by specific M30 staining in chimeric FasL-deficient mice that lacked FasL-positive myofibroblasts. In vitro, FasL-positive, but not FasL-negative myofibroblasts, induce mouse lung epithelial cell apoptosis. Thus myofibroblast cytotoxicity may underlie the absence of re-epithelialization, resulting in persistent lung fibrosis.
Key Words: apoptosis epithelial cell Fas ligand lung fibrosis myofibroblast
This article has been cited by other articles:

|
 |

|
 |
 
F. Strutz
The great escape--myofibroblasts in fibrosis and the immune system
Nephrol. Dial. Transplant.,
August 1, 2008;
23(8):
2477 - 2479.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Wallach-Dayan, R. Golan-Gerstl, and R. Breuer
Evasion of myofibroblasts from immune surveillance: A mechanism for tissue fibrosis
PNAS,
December 18, 2007;
104(51):
20460 - 20465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. G. Fridlender, P. Y. Cohen, O. Golan, N. Arish, S. Wallach-Dayan, and R. Breuer
Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis
Eur. Respir. J.,
August 1, 2007;
30(2):
205 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 American Thoracic Society.
|
|
|